Precipio Inc
NASDAQ:PRPO
Relative Value
The Relative Value of one PRPO stock under the Base Case scenario is 21.83 USD. Compared to the current market price of 5.8 USD, Precipio Inc is Undervalued by 73%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
PRPO Competitors Multiples
Precipio Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
Precipio Inc
NASDAQ:PRPO
|
8.2m USD | 0.5 | -1.4 | -1.1 | -0.9 | ||
US |
C
|
Cigna Group
XMUN:CGN
|
94.9B EUR | 0.5 | 19.8 | 10.2 | 13.6 | |
US |
Cigna Corp
NYSE:CI
|
99.5B USD | 0.5 | 19.3 | 10 | 13.3 | ||
US |
CVS Health Corp
NYSE:CVS
|
71.7B USD | 0.2 | 8.6 | 7.9 | 7.9 | ||
US |
Laboratory Corporation of America Holdings
NYSE:LH
|
16.9B USD | 1.4 | 39.2 | 11.9 | 17.9 | ||
DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.8B EUR | 0.7 | -26.5 | 10.1 | 22.6 | |
US |
Quest Diagnostics Inc
NYSE:DGX
|
15.1B USD | 1.6 | 18.1 | 10.8 | 14.6 | ||
DE |
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 0.6 | 23.9 | 7 | 16.6 | ||
DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 0.6 | 23.1 | 6.9 | 16.3 | |
US |
DaVita Inc
NYSE:DVA
|
11.9B USD | 1 | 17.3 | 8.4 | 12.3 | ||
US |
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |